Cargando…
Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma
BACKGROUND: Visual loss in glaucoma is associated with pathological changes in retinal ganglion cell (RGC) axons and a slow decline in the RGC population. Age and elevated intraocular pressure (IOP) are the main risk factors for glaucomatous loss of vision. Several studies have implicated the proinf...
Autores principales: | Roh, Miin, Zhang, Yan, Murakami, Yusuke, Thanos, Aristomenis, Lee, Sung Chul, Vavvas, Demetrios G., Benowitz, Larry I., Miller, Joan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388998/ https://www.ncbi.nlm.nih.gov/pubmed/22802951 http://dx.doi.org/10.1371/journal.pone.0040065 |
Ejemplares similares
-
Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
por: Mantopoulos, Dimosthenis, et al.
Publicado: (2011) -
RIP Kinase-Mediated Necrosis as an Alternative Mechanism of Photoreceptor Death
por: Murakami, Yusuke, et al.
Publicado: (2011) -
Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012) -
Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor
por: Lan, Joung-Liang, et al.
Publicado: (2017) -
Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
por: Moysidis, Stavros N., et al.
Publicado: (2012)